Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04425044
Other study ID # Au015
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 12, 2020
Est. completion date May 28, 2020

Study information

Verified date June 2020
Source Aarogyam UK
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objectives of this study are to test the level of accuracy of the prediction models that could be used as a 'digital test' to evaluate whether an individual is infected with COVID-19, based on their symptoms reported in the "AiM COVID-19" app


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date May 28, 2020
Est. primary completion date May 18, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Participants resident in India

- Voluntary completion of the self-test and evaluation.

Exclusion Criteria:

- People can not use mobile app

- Below 18 years old

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Other
No Intervention

Locations

Country Name City State
India NMP Medical Research Institite Jaipur Rajasthan
India Mothers Touch Foundation Mumbai Maharashtra

Sponsors (4)

Lead Sponsor Collaborator
Aarogyam UK Mothers Touch Foundation, NMP Medical Research Institute, University of Warwick

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fever Self reported body temperature (Degrees Celsius) 1 day
Secondary Shortness of Breath Self reported shortness of breath symptom (tick box) 1 day
Secondary Cough Self reported cough symptom (tick box) 1 day
Secondary Sore Throat Self reported soar throat symptom (tick box) 1 day
Secondary Headache Self reported headache symptom (tick box) 1 day
Secondary Muscle/ Joint Pain Self reported muscle/ joint pain symptom (tick box) 1 day
Secondary Diarrhoea Self reported diarrhoea symptom (tick box) 1 day
Secondary Vomiting/ Nausea Self reported vomiting/ nausea symptom (tick box) 1 day
Secondary Runny Nose Self reported runny nose symptom (tick box) 1 day
Secondary Loss of Smell/Taste Self reported loss of smell/ taste symptom (tick box) 1 day
Secondary Other symptoms Self reported other symptoms (tick box) 1 day
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3